Association of psoriatic disease with Uveitis: A danish nationwide cohort study

JAMA Dermatology

Volumn 151, Issue 11, 2015, Pages 1200-1205

  Egeberg, Alexander ^a   Khalid, Usman ^a   Gislason, Gunnar Hilmar ^a,b,c   Mallbris, Lotus ^d   Skov, Lone ^a   Hansen, Peter Riis ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Cardiovascular Epidemiology and Research   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DANISH CITIZEN; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SYMPTOM ASSESSMENT; UVEITIS; COMPLICATION; DENMARK; INCIDENCE; MIDDLE AGED; PATHOLOGY; RISK; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; ARTHRITIS, PSORIATIC; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PSORIASIS; RISK; SEVERITY OF ILLNESS INDEX; UVEITIS; YOUNG ADULT;

EID: 84946887352     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.1986     Document Type: Article

References (36)

1. Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology. 2012;225(2):121-126.
2. Gelfand JM, Neimann AL, Shin DB,Wang X, Margolis DJ, Troxel AB. Risk ofmyocardial infarction in patients with psoriasis. JAMA. 2006;296(14): 1735-1741.
3. Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173-1179.
4. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11(10):763-776.
5. Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339-1350.
6. Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease. Arthritis Res Ther. 2012;14(3):R99. doi:10.1186/ar3824.
7. El-Asrar AM, Struyf S, Kangave D, et al. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol. 2011;139(2):177-184.
8. Niccoli L, Nannini C, Cassara E, et al. Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis. 2012;15(4):414-418.
9. Canoui-Poitrine F, Lekpa FK, Farrenq V, et al. Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey. Arthritis Care Res (Hoboken). 2012;64(6):919-924.
10. Chandran NS, Greaves M, Gao F, Lim L, Cheng BC. Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis. J Dermatol. 2007;34(12):805-810.
11. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
12. Helweg-Larsen K, KjollerM, Davidsen M, Rasmussen NK, Madsen M; Danish National Cohort Study. The Danish National Cohort Study (DANCOS). Dan Med Bull. 2003;50(2):177-180.
13. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44(4): 445-448.
14. BaadsgaardM, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7)(suppl):103-105.
15. Adelzadeh L, Jourabchi N,Wu JJ. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions. J Eur Acad Dermatol Venereol. 2014;28(7):846-852.
16. LiWQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis. 2013;72(7):1200-1205.
17. Khalid U, Gislason GH, Hansen PR. Sarcoidosis in patients with psoriasis: a population-based cohort study. PLoS One. 2014;9(10):e109632. doi: 10.1371/journal.pone.0109632.
18. Fraga NA, Oliveira MdeF, Follador I, Rocha BdeO, Rego VR. Psoriasis and uveitis: a literature review. An Bras Dermatol. 2012;87(6):877-883.
19. Knox DL. Psoriasis and intraocular inflammation. TransAmOphthalmol Soc. 1979;77:210-224.
20. Durrani K, Foster CS. Psoriatic uveitis: a distinct clinical entity? Am J Ophthalmol. 2005;139(1):106-111.
21. Kilic B, Dogan U, Parlak AH, et al. Ocular findings in patients with psoriasis. Int J Dermatol. 2013;52(5):554-559.
22. Takeuchi M, Kezuka T, Sugita S, et al. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behcet's disease: a multicenter study. Ophthalmology. 2014;121(10): 1877-1884.
23. Diaz-LlopisM, Salom D, Garcia-de-Vicuna C, et al. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology. 2012;119(8):1575-1581.
24. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005;52(8):2447-2451.
25. Ooi KG, Galatowicz G, Calder VL, Lightman SL. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res. 2006;4(4):294-309.
26. Yoshimura T, Sonoda KH, Ohguro N, et al. Involvement of TH17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford). 2009;48(4):347-354.
27. Nair RP, Duffin KC, Helms C, et al; Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF pathways. Nat Genet. 2009;41(2):199-204.
28. Dong H, Li Q, Zhang Y, TanW, Jiang Z. IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population. PLoS One. 2013;8(6):e67505.
29. Liang D, Zuo A, Shao H, et al. IL-23 receptor expression on T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis. J Immunol. 2013;191(3):1118-1125.
30. Queiro R, Sarasqueta C, Belzunegui J, Gonzalez C, Figueroa M, Torre-Alonso JC. Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum. 2002;31(6):413-418.
31. Tay-KearneyML, SchwamBL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996;121(1): 47-56.
32. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. 2005;52(1): 269-274.
33. Llorenc V, Mesquida M, Sainz de la Maza M, et al. Epidemiology of uveitis in aWestern urban multiethnic population: the challenge of globalization [published online February 15, 2015]. Acta Ophthalmol. doi:10.1111/aos.12675.
34. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) Project Team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-385.
35. Gritz DC,Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111(3):491-500.
36. Khan MA. HLA-B27 and its subtypes inworld populations. Curr Opin Rheumatol. 1995;7(4):263-269.